Clinical Edge Journal Scan

Children with atopic dermatitis prone to develop proinflammatory dietary pattern


 

Key clinical point: Children diagnosed with atopic dermatitis (AD) within the first 10 years of life are more likely to develop a more proinflammatory dietary pattern and consume less fiber and several vitamins, which may worsen the atopic outcome itself.

Major finding: The intake of fiber ( P = .04), vitamin C ( P = .02), vitamin E ( P = .03), and vitamin B 7 (biotin) ( P = .047) were significantly lower among children who developed vs did not develop AD in the first 10 years of life, with a significant association observed between presence of AD and a proinflammatory dietary pattern at 10 years of age (odds ratio 2.22; P = .02).

Study details: Findings are from the population-based LiNA cohort study including 211 10-year-old children.

Disclosures: This LiNA study was funded by the Department of Environmental Immunology, Helmholtz Centre for Environmental Research. JR Hebert declared owning controlling interest in Connecting Health Innovations LLC.

Source: Schütte O et al. Pro-inflammatory diet pictured in children with atopic dermatitis or food allergy: Nutritional data of the LiNA cohort. Front Nutr. 2022;9:868872 (Apr 8). Doi: 10.3389/fnut.2022.868872

Recommended Reading

Clinical Edge Journal Scan Commentary: Atopic Dermatitis May 2022
MDedge Dermatology
Steroid phobia drives weaker prescribing, nonadherence for AD
MDedge Dermatology
Moderate-to-severe atopic dermatitis: Abrocitinib shows promise in patients who switch from dupilumab
MDedge Dermatology
Atopic dermatitis: Higher threshold efficacy response and QoL benefits with abrocitinib
MDedge Dermatology
Atopic dermatitis: Baricitinib+TCS shows promise in patients with inadequate response to CyA
MDedge Dermatology
Atopic dermatitis: Dupilumab shows potential as a long-term, continuous treatment option
MDedge Dermatology
Higher sensitivity to contact allergens in children with atopic dermatitis
MDedge Dermatology
Nemolizumab safe and efficacious in relieving pruritus and reducing severity of atopic dermatitis
MDedge Dermatology
Dupilumab beneficial for adolescents with moderate-to-severe atopic dermatitis in the real world
MDedge Dermatology
Meta-analysis highlights favorable efficacy and safety of antioxidants in atopic dermatitis
MDedge Dermatology